Maiolo, Elena
 Distribuzione geografica
Continente #
NA - Nord America 1.893
EU - Europa 1.531
AS - Asia 1.406
SA - Sud America 199
AF - Africa 38
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.079
Nazione #
US - Stati Uniti d'America 1.814
SG - Singapore 563
DE - Germania 497
CN - Cina 309
IT - Italia 248
VN - Vietnam 232
PL - Polonia 195
SE - Svezia 177
BR - Brasile 163
FR - Francia 108
GB - Regno Unito 93
IN - India 66
BD - Bangladesh 52
CA - Canada 50
FI - Finlandia 47
JP - Giappone 38
IE - Irlanda 34
UA - Ucraina 34
ID - Indonesia 29
TR - Turchia 22
RU - Federazione Russa 21
HK - Hong Kong 19
MX - Messico 18
AT - Austria 11
NL - Olanda 11
AR - Argentina 10
CI - Costa d'Avorio 10
AU - Australia 9
ZA - Sudafrica 9
KR - Corea 8
BE - Belgio 7
ES - Italia 7
IL - Israele 7
IQ - Iraq 7
PY - Paraguay 7
CH - Svizzera 6
IR - Iran 6
LT - Lituania 6
PK - Pakistan 6
SA - Arabia Saudita 6
TN - Tunisia 6
CL - Cile 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
EG - Egitto 4
JO - Giordania 4
MY - Malesia 4
VE - Venezuela 4
AL - Albania 3
AZ - Azerbaigian 3
EC - Ecuador 3
GR - Grecia 3
HN - Honduras 3
JM - Giamaica 3
LB - Libano 3
MA - Marocco 3
PE - Perù 3
UY - Uruguay 3
BG - Bulgaria 2
CG - Congo 2
CY - Cipro 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
OM - Oman 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BY - Bielorussia 1
CO - Colombia 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
PW - Palau 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
Totale 5.079
Città #
Singapore 370
Ashburn 208
Warsaw 185
Chandler 168
San Jose 168
Fairfield 97
Beijing 69
Ho Chi Minh City 68
New York 65
Hanoi 64
Rome 61
Houston 51
Los Angeles 48
Munich 48
The Dalles 44
Woodbridge 43
Seattle 42
Dallas 38
Wilmington 38
Ann Arbor 35
Hefei 35
Dublin 33
Nürnberg 32
Tokyo 32
Lauterbourg 31
Helsinki 29
San Mateo 29
Jacksonville 26
Frankfurt am Main 25
Nanjing 25
Jakarta 24
Cambridge 19
Milan 19
Buffalo 18
Chicago 18
Council Bluffs 18
Dearborn 18
Hong Kong 18
Bremen 16
Haiphong 16
Hyderabad 16
London 16
Boston 15
Orem 15
Santa Clara 15
Montreal 14
Cattolica 13
Da Nang 13
Moscow 13
Toronto 13
São Paulo 12
Boardman 11
Marseille 11
Princeton 11
Abidjan 10
Guangzhou 10
Kent 10
Mexico City 10
Nuremberg 10
Phoenix 10
Redwood City 10
St Louis 10
Atlanta 9
Brooklyn 9
Chennai 9
Denver 9
Fremont 9
San Francisco 9
Nanchang 8
Seoul 8
Shanghai 8
Stockholm 8
Turku 8
Wroclaw 8
Brussels 7
Izmir 7
Paris 7
Poplar 7
Redmond 7
Tianjin 7
Asunción 6
Belo Horizonte 6
Bến Tre 6
Hangzhou 6
Johannesburg 6
Kunming 6
Lancaster 6
Naples 6
Vienna 6
Amsterdam 5
Bovisio-Masciago 5
Kish 5
Kocaeli 5
Lappeenranta 5
Lawrence 5
Manchester 5
Roubaix 5
Amman 4
Ankara 4
Changsha 4
Totale 2.909
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 434
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 346
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 330
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 298
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 282
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 242
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 223
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 200
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 191
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 182
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 177
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 175
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 175
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 160
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 156
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 151
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 145
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 144
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 141
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 120
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 117
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 107
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 106
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 101
Baseline Tumor Burden Assessed With AI-Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR-T in Aggressive B-Cell Lymphoma 96
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 77
Epstein-Barr Virus (EBV)-Associated Haemophagocytic Syndrome 56
The predictive power of 18F-FDG PET/CT two-lesions radiomics and conventional models in classical Hodgkin’s Lymphoma: a comparative retrospectively-validated study 52
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements 44
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 39
The Impact of Radiotherapy and Attenuated Chemotherapy Regimens in Older Patients with Classic Hodgkin Lymphoma: A Real-Life Study from the ReLLi Network 33
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 31
Baseline 18F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions 30
Totale 5.161
Categoria #
all - tutte 17.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022267 36 22 5 6 21 5 17 32 22 26 39 36
2022/2023467 68 59 24 92 21 49 31 46 47 6 14 10
2023/2024277 4 68 8 16 8 51 8 43 2 1 28 40
2024/2025714 28 24 52 38 65 30 46 19 68 71 142 131
2025/20261.948 200 63 106 191 342 88 409 114 111 141 72 111
2026/2027126 126 0 0 0 0 0 0 0 0 0 0 0
Totale 5.161